Enantioselective capillary electrophoretic methods were elaborated for the determination of the enantiomeric purity of (R)-MDL 100,907 and its preparatively resolved key intermediate compound during the synthesis route. The pK a values of the intermediate compound and the end product determined by CE were 10.5 ± 0.1 and 9.0 ± 0.1, respectively.
impurity migrates before the main component. The fact that the consecutive steps of the synthesis do not affect the enantiomeric purity was verified by the other, newly developed CE method. The enantiomers of rac-MDL 100,907 were resolved by 15 mM carboxymethyl--cyclodextrin at pH 3. The applicability (selectivity, LOD, LOQ, repeatability, precision and accuracy) of the methods was studied as well. antagonist [1] . Its R-enantiomer binds to its receptor with higher affinity (K i~ 0.4 nM) than its racemic form (K i~ 2.1 nM) [2] . MDL 100,907 has about 100-fold or greater selectivity for 5-HT 2A than for the other 5-HT receptor subtypes [3] [4] . This drug is widely used in the investigation of the 5-HT 2A receptor function [1, [5] [6] [7] [8] . The [ 11 C] MDL 100,907, the radioactive derivative is applied in positron emission tomography (PET) for receptor mapping and determination of drug-induced receptor occupancy in pathological conditions (e.g. in schizophreny) [2] [3] [4] [5] [6] .
Introduction
The synthesis route (Scheme 1) described by Herth [2] was chosen from the available methods [2, [9] [10] to prepare (R)-MDL 100,907 for R&D purposes with an 3% enantiomer impurity as maximum. The preparative chiral resolution of the key intermediate (compound 7:
(2,3-dimethoxyphenyl)(piperidin-4-yl)methanol) by the isolation of the diastereomeric salt pairs of the enantiomers of compound 7 prepared with (
an important step. This step is followed by an N-alkylation procedure resulting in the (R)-MDL 100,907, the end product (compound 10). The efficiency of the preparative optical resolution of compound 7 can be verified either by NMR [10] or by HPLC [2] . For this indirect NMR method the sample (compound 8) goes through a diastereomeric salt derivation with (R)-1,1'-binaphthyl-2,2'-diyl hydrogen phosphate.
The aim of our study is to develop an easier, direct stereoselective method which consumes less time, solvents and samples. Therefore, novel capillary electrophoretic (CE) methods for the determination of enantiomeric purity of the key intermediate (compound 8) and the end product (compound 10) were elaborated.
[Scheme 1] 
Materials and Methods

Materials
Anhydrous (+)-di-O,O'-p-toluyl-D-tartaric
Capillary electrophoresis
where t is the migration time of the enantiomers (1, 2 in lower index), w (0.5) is the peak width at half height.
Estimation of pKa values of the analytes
Experimental pK a values of the analytes were determined from the effective mobilities (μ eff ) measured at a pH where the analytes are in fully ionized state (pH 4) and at pH 9 where the analytes are mixtures of ionized and neutral states. pK a value of a mono-basic analyte can be calculated from equation 2 [12, 13] . 
Determination of the stability constants of the complexes formed with CDs
The apparent stability constants of complexes (K') were determined at pH 3 and 5. 
where μ free is the mobility of an analyte in BGE without selector. RSD values of the measured and calculated parameters were less than 10%.
Evaluation of method applicability
The homogeneity of the peaks of the enantiomers of compound 7 and MDL 100,907 was studied by injecting 0.1 mg/ml sample solutions of the raceme compounds. The identification of the peaks was carried out by spiking the raceme sample with the purified Renantiomers (compounds 8 and 10). Linearity of the methods for the separation of compound 7 or MDL 100,907 was tested by raceme standards at 10, 20, 30, 40, 50, 60, 80, 100 µg/ml concentrations (i.e. 5, 10, 15, 20, 25, 30, 40, 50 µg/ml concentrations for the enantiomers respectively). Intra-day repeatability of the methods was studied by three repetitive injections of 5, 10 and 25 µg/ml concentrations of compounds 7 and rac-MDL 100,907, respectively.
The inter-day repeatability was determined by repeating the above procedure at three consecutive days. Six-six samples with known concentrations of raceme solutions of compound 7 and MDL 100,907 (5 µg/ml and 10 µg/ml, respectively) were prepared and the intra-day accuracies of the methods were established by the determination of the recoveries of the samples calculating their concentrations from the calibration.
Results and Discussion
Method development and optimization
Experimental acidic dissociation constants (pK a ) measured by CE were 10.5 ± 0.1 and 9.0 ± 0.1 for compound 7 and for MDL 100,907, respectively. These data are in a good agreement with the predicted pK a values (10.05 and 8.75) calculated by "Marvin" software.
Compound 7 and MDL 100,907 have basic character therefore their chiral separations were elaborated at pH 5 and pH 3 in their fully ionized state. According to the literature, the neutral or the anionic CD derivatives should be good choices for selectors when the analytes have cationic character [21] . Two neutral cyclodextrins -TRIMEB and RAMEB -and four acidic CDs -CMBCD, CMGCD, SBEBCD and SBEGCD -were chosen as potential selectors both for compound 7 and rac-MDL 100,907. The two neutral CD derivatives can not resolve our analytes. Since the migration times are high and the peak shapes show torsions in the presence of sulfobuthylether CD derivatives at pH 3 these results are not discussed here.
Apparent stability constants (K') and the mobilities (µ compl ) of negatively charged CD complexes were determined (Table 1) as well. The acidic CD derivatives studied forms more stable complexes with the enantiomers of rac-MDL 100,907 than with the enantiomers of compound 7.
[ Table 1 ]
Although the K' values of the enantiomer pairs belonging to a given selector are slightly different these differences still resulted in the predicted migration orders of the enantiomers (EMO) in most but in one cases. Mainly the K' of the S-enantiomers is higher than that of the R-enantiomers giving 'RS' migration order. On the contrary, the reversed K' ratio obtained for compound 7 in the presence of SBEBCD is concomitant with the 'SR' migration order. The corresponding µ compl -s differ from each other substantially only in the case of compound 7 using CMBCD at pH 3 presumably because this CD derivative contains a mixture of isomers [22] . The fact that here µ compl,R > µ compl,S could be the reason that the EMO is 'RS' despite that the EMO predicted from the difference in K' should be the opposite of it, namely 'SR'. The resolutions achieved and the corresponding EMOs are shown in Table 1 . In CE good resolutions can be experienced for compound 7 by SBEBCD and SBEGCD at pH 5
and by CMGCD at pH 5 and at pH 3 too. Despite the fact, that improved resolutions can be obtained by CMGCD or SBEGCD as well, SBEBCD results in a more favorable EMO since the impurity migrates before the main component ( Fig. 1 ) in contrast to the reversed EMO obtained by CMGCD or SBEGCD (Table 1) . Appropriate separation for the enantiomers of the rac-MDL 100,907 can be achieved only by CMGCD at pH 3 ( Fig. 1) . However, the contaminant S-enantiomer migrates slower than the R-enantiomer. It is worth mentioning that CMGCD is only partially ionized at pH 3 because its pKa value is approximately 3.75.
[ Fig. 1] The concentrations of the CD derivatives were also optimized according to the measured K' and µ compl values. Selectivities slightly increase with increasing concentrations of the selectors in the 5-15 mM concentration range in both cases. According to our experience 15 mM of the selectors provide appropriate resolutions (cf. Fig. 1 ). Whereas higher concentrations of the selectors may improve selectivity but at the same time undesirable Joule heating and peak torsions can occur. Furthermore, in the presence of higher concentrations of SBEBCD compound 7 co-migrates with EOF and therefore the enantiomer ratio of the analyte can not be evaluated.
The achiral CE methods in the absence of CD selectors at pH 5 and at pH 3 are suitable (R s = 8.12,  = 1.07 and R s = 13.36,  = 1.16, respectively) for determining the amount of the remaining compound 7 impurity in MDL 100,907 sample.
Method application
Applicability of both proposed methods was checked as well [ Table 2 ] according to the recommendations of the Good Laboratory Practice [23] . The values of the intra-day and inter-day repeatability of the S-enantiomers were less than 10% being below the acceptable maximum value for this technique. Consequently both methods have good precision. The enantiomer impurities in compound 8 and in the end product, compound 10 were determined as well. The ratios of the contaminant enantiomers are a little bit high but these values are acceptable in the case of a product synthesized for R&D purposes. The preparative optical resolution step of the synthesis needs to be improved if the drug is produced for medical purposes. The enantiomer excess did not increase substantially during the synthesis steps carried out after the optical resolution of the intermediate compound. It means that this last part of synthesis route does not involve steps resulting in racemization.
[ Table 2 ]
Conclusions
A chiral CE method was developed using SBEBCD at pH 5 for the evaluation of the enantiopurity of the intermediate compound 8 purified by stereoselective resolution during the synthesis route of (R)-MDL 100,907. We determined by the other method elaborated here
(applying CMGCD at pH 3) that the consecutive steps of the synthesis could not spoil the enantiomer purity of the end product. This latter method and the method at pH 5 without selector are equally appropriate to verify the amount of the contaminant intermediate compounds.
Scheme 1: Synthesis route of (R)-MDL 100,907 [2] Values refer to the contaminant S-enantiomers y = peak area corrected with migration time, x= concentration of the analytes in μg/ml. Precision data are presented the average reproducibility values calculated from the individual RSD values in the brackets referring to the 5, 10, 25 µg/ml S-enantiomer samples, respectively. Recovery data were determined at 5 µg/ml and 10 µg/ml concentrations of compound 7 and MDL 100,907, respectively.
